Bortezomib cancer drug molecule

Bortezomib cancer drug molecule

C028/8023 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.1MB

Downloadable file size: 2.6MB

Price image Pricing

Please login to use the price calculator


Caption: Bortezomib. Molecular model of the proteasome inhibitor drug bortezomib (chemical formula C19.H25.B.N4.O4), used to treat cancers. This was the first therapeutic proteasome inhibitor to be tested in humans. It has been used in the treatment of multiple myeloma and mantle cell lymphoma. Atoms are represented as spheres and are colour-coded: carbon (light blue), hydrogen (white), nitrogen (dark blue), oxygen (red) and boron (yellow).

Release details: Model release not required. Property release not required.

Keywords: 1, anti-cancer, artwork, biochemical, biochemistry, biological, biology, black background, bortecad, bortezomib, cancer, cancer treatment, chemical, chemistry, chemotherapy, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, digitally generated, drug, graphic, healthcare, illustration, inhibitor, lymphoma, medical, medication, medicine, model, molecular, molecule, myeloma, neomib, no one, no-one, nobody, oncology, pharmaceutical, pharmaceutics, pharmacological, pharmacology, plain background, protease, proteasome inhibitor, proteinase, research, space-fill, space-filled, spacefill, spacefilled, structure, therapeutic, treatment, velcade

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.